Hepatic Fibrosis Test YRA317 // YRA321

The Hepatic Fibrosis Test YRA317//YRA321 is an essential tool for the early detection and monitoring of liver fibrosis, a condition that can lead to cirrhosis if not identified and managed timely. This test is compatible with the Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, ensuring accurate and reliable results. Early intervention is crucial, as initial stages of hepatic fibrosis are often reversible, greatly enhancing patient prognosis and quality of life. With this test, healthcare professionals can take a proactive approach to patient management, potentially reversing or delaying disease progression.

Market Price

The market price for hepatic fibrosis tests can vary widely depending on the supplier and specific test configurations. Generally, you can expect prices to range between $500 and $1000 per testing kit. To get the most accurate and competitive pricing, we recommend generating a quote through the Kalstein Plus platform, where you can explore comprehensive options tailored to your requirements.

Frequently Asked Questions

What parameters does the Hepatic Fibrosis Test evaluate?

The test evaluates several crucial parameters including PIIINP, CIV, LN, HA, and CG, which are vital for diagnosing and assessing liver fibrosis.

What is the storage condition for the testing kits?

The kits should be stored between 2-8°C to ensure their efficacy and longevity.

Advantages and Disadvantages

Advantages: The Hepatic Fibrosis Test offers precise and early detection of liver conditions, helping in timely treatment and management. Compatibility with advanced analyzers ensures high accuracy and reliability.

Disadvantages: The test requires specific equipment for analysis which might not be available in all laboratories, which could limit accessibility. Additionally, initial costs might be significant for smaller clinics.

Product Use in the Field

The Hepatic Fibrosis Test is typically used in healthcare settings where early diagnosis and monitoring of liver diseases are critical. Medical professionals administer the test to assess the severity of fibrosis in the liver and to make informed decisions regarding patient treatment plans. It plays a significant role in guiding interventions that can halt or reverse the progression of liver fibrosis.

Recommendations

For optimal use of the Hepatic Fibrosis Test, ensure your medical facility is equipped with compatible Chemiluminescence Immunoassay Analyzers. Regular calibration of the equipment is recommended to maintain accuracy. Join Kalstein Plus for the latest updates, exclusive offers, and to streamline the procurement process. Engage with our online platform to generate a tailored quote and make an informed purchase decision today.

Features

• Comprehensive detection parameters: PIIINP, CIV, LN, HA, CG.
• Compatible with YR06389 and YR06390 analyzers.
• Stored at optimal conditions: 2-8°C.
• Supports high throughput with 50 tests per box.
• Certified for quality and safety: CE, ISO13485, FSC.

Technical Specifications